Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,945 | -24,221 | -27,646 | -12,478 | -5,951 |
| Depreciation Amortization | 53 | 67 | 58 | 34 | 24 |
| Accounts receivable | -487 | 903 | -64 | -2,058 | -99 |
| Accounts payable and accrued liabilities | 150 | -1,172 | 352 | 1,175 | 68 |
| Other Working Capital | -2,111 | -948 | 4,007 | -1,949 | 555 |
| Other Operating Activity | 954 | 1,760 | 2,923 | 2,902 | 161 |
| Operating Cash Flow | $-15,386 | $-23,611 | $-20,370 | $-12,374 | $-5,242 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,297 | 15,882 | 19,601 | -45,951 | -24 |
| PPE Investments | N/A | -3 | -68 | 761 | -38 |
| Other Investing Activity | 0 | 0 | 0 | 4 | 0 |
| Investing Cash Flow | $2,297 | $15,879 | $19,533 | $-45,186 | $-62 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,868 | 3,504 | 410 | 58,647 | 4,750 |
| Common Stock Repurchased | N/A | N/A | -1,218 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 2,427 | 0 |
| Financing Cash Flow | $9,868 | $3,504 | $-808 | $61,074 | $4,750 |
| Beginning Cash Position | 9,368 | 13,596 | 15,241 | 11,727 | 12,281 |
| End Cash Position | 6,147 | 9,368 | 13,596 | 15,241 | 11,727 |
| Net Cash Flow | $-3,221 | $-4,228 | $-1,645 | $3,514 | $-554 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,386 | -23,611 | -20,370 | -12,374 | -5,242 |
| Capital Expenditure | N/A | -3 | -68 | -239 | -38 |
| Free Cash Flow | -15,386 | -23,614 | -20,438 | -12,613 | -5,280 |